457-21736-54097
4 vaccinations
4 coded responses
39 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 627 / IL
- Registered
- 2021-02-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-17
Dose 1 — Pfizer-BioNTech
-
2021-02-19
Registered in v-safe
-
2021-02-19
Survey response — days 1–6 daily, dose 1MedDRA: Asthma, Dyspnoea, Nausea, Pre-existing disease — Feeling: GoodFree text: Shortness of breath/but I have asthma. Stomach was a little queasy on 2nd day.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-20
- 2021-02-21
- 2021-02-22
-
2021-02-23
Survey response — days 1–6 daily, dose 1MedDRA: Asthenia, Fatigue — Feeling: Good · Headache, Fatigue or tirednessFree text: I just feel little weak not like my usual self. Little more tired.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-24
- 2021-03-03
-
2021-03-10
Dose 2 — Pfizer-BioNTech
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-25
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-21
-
2021-06-09
Survey response — 3 months, dose 2MedDRA: Asthma, Bronchitis chronic, Malaise, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I have asthmatic/bronchitis right now and am under the weather. Dont have any COVID symptoms was tested and it was negative.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-09
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-08
-
2021-09-25
Dose 3 — Pfizer-BioNTech
- 2021-10-01
- 2021-10-02
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-06
-
2021-11-11
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-12-25
-
2022-03-26
Survey response — 6 months, dose 3MedDRA: Malabsorption, Superior mesenteric artery syndrome, Weight decreased, Weight gain poor — Feeling: GoodFree text: Diagnosed with SMA Snydrome (Superior Mesentric Artery Snydrome). Extreme weight loss. Having hard time gaining weight as body will not absorb food. Waiting for surgery. Six months waiting period.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-06
Dose 4 — Pfizer-BioNTech
- 2022-04-14
- 2022-04-20
- 2022-04-27
- 2022-05-04
- 2022-05-11
- 2022-05-18
- 2022-07-06
- 2022-10-05
- 2023-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-17 | Pfizer-BioNTech | |
| 2 | 2021-03-10 | Pfizer-BioNTech | |
| 3 | 2021-09-25 | Pfizer-BioNTech | No |
| 4 | 2022-04-06 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Shortness of breath/but I have asthma. Stomach was a little queasy on 2nd day.
Systemic reaction (other): I just feel little weak not like my usual self. Little more tired.
Release 9 — 3 months, dose 2
Symptoms: I have asthmatic/bronchitis right now and am under the weather. Dont have any COVID symptoms was tested and it was negative.
Release 11 — 6 months, dose 3
Symptoms: Diagnosed with SMA Snydrome (Superior Mesentric Artery Snydrome). Extreme weight loss. Having hard time gaining weight as body will not absorb food. Waiting for surgery. Six months waiting period.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | ✓ | · | ✓ |
| SD | Bronchitis chronic | ○ | ✓ | ○ |
| SD | Malabsorption | · | · | ✓ |
| SD | Malaise | ✓ | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SD | Superior mesenteric artery syndrome | · | · | ✓ |
| SD | Weight decreased | · | · | ✓ |
| SD | Weight gain poor | · | · | ✓ |
| SRO | Asthenia | ✓ | ✓ | ✓ |
| SRO | Asthma | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release